PCVX - CIK 0001649094
The table below shows Vaxcyte, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $173.96M | $387.88M | $397.45M | $834.66M | $68.98M | $386.20M |
| Short-term investments | $1.39B | $1.36B | $682.78M | $96.72M | $176.99M | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.63B |
| $1.79B |
| $1.10B |
| $942.55M |
| $256.35M |
| $389.00M |
| Property, plant & equipment | $257.37M | $198.04M | $79.63M | $10.36M | $7.95M | $3.27M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $3.00B | $3.51B | $1.41B | $1.01B | $324.34M | $392.83M |
| Accounts payable | $70.90M | $48.45M | $14.59M | $9.79M | $6.76M | $29.79M |
| Total current liabilities | $205.75M | $140.18M | $145.34M | $40.52M | $28.72M | $46.86M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $317.21M | $205.50M | $167.45M | $52.56M | $40.32M | $46.98M |
| Retained earnings | -$2.15B | -$1.39B | -$924.39M | -$522.13M | -$298.64M | -$198.56M |
| Total equity | $2.69B | $3.31B | $1.24B | $953.61M | $284.02M | $345.84M |